As of April 2023 Gilead Sciences has a market cap of $103.61 Billion. This makes Gilead Sciences the world's 135th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2023 | $103.61 B | -3.77% |
2022 | $107.67 B | 18.26% |
2021 | $91.05 B | 24.68% |
2020 | $73.03 B | -11.22% |
2019 | $82.26 B | 2.59% |
2018 | $80.18 B | -14.31% |
2017 | $93.58 B | -0.81% |
2016 | $94.34 B | -34.43% |
2015 | $143.89 B | 1.84% |
2014 | $141.29 B | 22.62% |
2013 | $115.23 B | 106.55% |
2012 | $55.79 B | 81.47% |
2011 | $30.74 B | 5.78% |
2010 | $29.06 B | -25.35% |
2009 | $38.93 B | -16.39% |
2008 | $46.56 B | 8.95% |
2007 | $42.73 B | 42.74% |
2006 | $29.94 B | 23.89% |
2005 | $24.16 B | 53.89% |
2004 | $15.70 B | 26.36% |
2003 | $12.42 B | 84.99% |
2002 | $6.71 B | 5.91% |
2001 | $6.34 B |
On Mar 31st, 2023 the market cap of Gilead Sciences was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | $483.57 B | 366.71% | ๐บ๐ธ USA |
![]() Pfizer PFE | $231.78 B | 123.70% | ๐บ๐ธ USA |
![]() AbbVie ABBV | $281.15 B | 171.34% | ๐บ๐ธ USA |
![]() Eli Lilly LLY | $327.05 B | 215.65% | ๐บ๐ธ USA |
![]() Amgen AMGN | $130.46 B | 25.92% | ๐บ๐ธ USA |
![]() Biogen BIIB | $40.17 B | -61.23% | ๐บ๐ธ USA |
![]() Illumina ILMN | $38.15 B | -63.18% | ๐บ๐ธ USA |
![]() Vertex Pharmaceuticals VRTX | $81.25 B | -21.58% | ๐บ๐ธ USA |
![]() Merck MRK | $270.08 B | 160.66% | ๐บ๐ธ USA |